PLN and myocardial infarction: The findings demonstrate that AEOL reduces mitochondrial ROS production, decreases myocardial infarct size, and improves cardiac function through NRF2-mediated upregulation of DWORF, which enhances SERCA2a activity by disrupting the phospholamban-SERCA2a interaction.